Moderna Flu Vaccine -3.4% After FDA Panel Backs Shot
Can the Moderna Flu Vaccine turn an FDA panel win into a real growth story before Wall Street loses patience?
Moderna Strategy +13%: In Vivo CAR-T Surge Lifts MRNA
Can Moderna Strategy turn a vaccine story into a multi-platform biotech growth engine before the market prices it in?
Eli Lilly Acquisition $3.8B Push Opens Vaccine Growth Lane
Can Eli Lilly turn obesity cash into its next blockbuster by spending $3.83 billion on vaccines?
Moderna Patent Settlement +11.3% Surge: Is the $2.25B Hit Worth the Clarity?
Does Moderna’s billion‑dollar patent peace deal finally clear the runway for its mRNA pipeline—or just cap the upside? Moderna Patent Settlement: Why Wall Street Is Cheering the MoveModerna…